101 related articles for article (PubMed ID: 38672156)
1. Neuroendocrine Neoplasia: From Pathophysiology to Novel Therapeutic Approaches.
Carsote M; Nistor C
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672156
[TBL] [Abstract][Full Text] [Related]
2. Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology.
Kidd M; Modlin IM; Bodei L; Drozdov I
Cell Mol Gastroenterol Hepatol; 2015 Mar; 1(2):131-153. PubMed ID: 28210673
[TBL] [Abstract][Full Text] [Related]
3. The biochemical utility of chromogranin A, chromogranin B and cocaine- and amphetamine-regulated transcript for neuroendocrine neoplasia.
Bech PR; Martin NM; Ramachandran R; Bloom SR
Ann Clin Biochem; 2014 Jan; 51(Pt 1):8-21. PubMed ID: 23939195
[TBL] [Abstract][Full Text] [Related]
4. Long-term effect of everolimus in recurrent thymic neuroendocrine neoplasia.
Lang M; Hackert T; Anamaterou C
Clin Endocrinol (Oxf); 2021 Nov; 95(5):744-751. PubMed ID: 34323309
[TBL] [Abstract][Full Text] [Related]
5. Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012-2018: A Retrospective, Population-Based Study.
White BE; Russell B; Remmers S; Rous B; Chandrakumaran K; Wong KF; Van Hemelrijck M; Srirajaskanthan R; Ramage JK
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980749
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Neuroendocrine Tumors.
Fraenkel M; Faggiano A; Valk GD
Front Horm Res; 2015; 44():1-23. PubMed ID: 26303701
[TBL] [Abstract][Full Text] [Related]
7. Personalized treatment of well-differentiated gastric neuroendocrine tumors based on clinicopathological classification and grading: A multicenter retrospective study.
Huang J; Liu H; Yang D; Xu T; Wang J; Li J
Chin Med J (Engl); 2024 Mar; 137(6):720-728. PubMed ID: 38384175
[TBL] [Abstract][Full Text] [Related]
8. Type 3 gastric neuroendocrine neoplasms: the rising promise of conservative endoscopic management.
Dell'Unto E; Esposito G; Rinzivillo M; Marasco M; Annibale B; Panzuto F
Front Med (Lausanne); 2024; 11():1327864. PubMed ID: 38357651
[TBL] [Abstract][Full Text] [Related]
9. Transformation of G1-G2 neuroendocrine tumors to neuroendocrine carcinomas following peptide receptor radionuclide therapy.
Cordero-Hernandez IS; Ross AC; Dasari A; Halperin DM; Chasen B; Yao JC
Endocr Relat Cancer; 2024 Apr; 31(4):. PubMed ID: 38329269
[TBL] [Abstract][Full Text] [Related]
10. Current and emerging strategies for the management of advanced/metastatic lung neuroendocrine tumors.
Rutherford M; Wheless M; Thomas K; Ramirez RA
Curr Probl Cancer; 2024 Apr; 49():101061. PubMed ID: 38281845
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies: Preliminary Evidence From a Clinical Pilot Study.
Trautwein NF; Hinterleitner C; Kiefer LS; Singer S; Mattern S; Schwenck J; Reischl G; Sipos B; Lauer UM; Dittmann H; Zender L; la Fougère C; Hinterleitner M
Clin Nucl Med; 2024 Mar; 49(3):207-214. PubMed ID: 38271237
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic Management of Gastro-Entero-Pancreatic Neuroendocrine Tumours: An Overview of Proposed Resection and Ablation Techniques.
Chacchi-Cahuin R; Despott EJ; Lazaridis N; Rimondi A; Fusai GK; Mandair D; Anderloni A; Sciola V; Caplin M; Toumpanakis C; Murino A
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254841
[TBL] [Abstract][Full Text] [Related]
13. Peptide receptor radionuclide therapy combinations for neuroendocrine tumours in ongoing clinical trials: status 2023.
di Santo G; Santo G; Sviridenko A; Virgolini I
Theranostics; 2024; 14(3):940-953. PubMed ID: 38250038
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
